A standard IVF + ICSI cycle at NABH-accredited partner hospitals in India typically costs around ₹1,50,000–₹3,50,000 (about $1,600–$3,715; AUD 2,220–5,180; £1,180–2,745). Adding ICSI usually increases the cost by ₹20,000–₹50,000 (around $220–$530; AUD 295–740; £158–392). Medicines are separate and can add another ₹50,000–₹1,00,000 depending on the treatment plan. Divinheal provides a clear, itemised estimate in AUD or GBP before treatment begins for the full cost.

IVF with ICSI at Divinheal partner hospitals costs ₹1,50,000–₹3,50,000 for a complete cycle. This covers monitoring, egg retrieval, the ICSI fertilisation step, embryo culture, and one embryo transfer. In Australia, the same combined treatment costs AUD 10,000–18,000. In the UK, it costs £7,000–£15,000. Divinheal links patients with NABH/JCI-accredited partner hospitals with clear, itemised pricing for all treatments.

ICSI is a lab fertilisation step used as part of an IVF cycle. A single healthy sperm is selected under 200–400× magnification. It is then injected directly into the centre of a mature egg. This skips the need for the sperm to find and enter the egg on its own. ICSI is mainly used for male infertility and past IVF fertilisation failure.

The difference is in how fertilisation happens in the lab. Standard IVF puts sperm near the egg in a dish. It lets fertilisation happen naturally. ICSI injects one selected sperm directly into each mature egg. Both methods produce embryos that grow in the lab and are then placed into the uterus. ICSI adds the cost of the lab doctor’s time and special equipment to the base IVF price.

No. ICSI is a lab step done within an IVF cycle — it is not a separate treatment. It needs mature eggs, which can only be collected through IVF (ovarian stimulation and egg retrieval). ICSI is the fertilisation step within the IVF cycle. You cannot choose ICSI on its own.

For the right cases — severe male infertility, past fertilisation failure — ICSI achieves fertilisation rates of 70–80% compared with 20–30% using standard IVF for the same patients. For couples with normal sperm and no past fertilisation failure, adding ICSI does not improve live birth rates. It is not routinely recommended. Overall live birth rates depend on embryo quality and the female partner’s uterus — not on the fertilisation method used.

Ovarian stimulation takes about 8–14 days with daily injections and regular scans. Then eggs are collected in a short 20–30 minute procedure under light sedation, and sperm is collected or retrieved if needed. In the lab, each egg is fertilised using ICSI, embryos are grown for 5–6 days, and the best blastocyst is transferred into the uterus in a quick 15–20 minute procedure without anaesthesia. A pregnancy test is done about 10–14 days later.

For the female partner: egg retrieval is under sedation — no pain during the procedure. Mild cramping for 24–48 hours afterward is normal. Embryo transfer requires no anaesthesia. For the male partner: standard sperm collection is non-invasive and painless. TESA (surgical retrieval under local anaesthetic) causes mild scrotal aching for 2–3 days. Micro-TESE (under general anaesthesia) causes post-operative scrotal discomfort for 5–7 days, managed with prescribed pain relief.

A pregnancy blood test is booked 10–14 days after embryo transfer — about 4–6 weeks after the start of ovarian stimulation. That blood test gives a clear positive or negative result. Many patients do not get pregnant on the first cycle. Total success rates after 2–3 cycles are much higher than after just one attempt. India’s lower costs make planning for 2 cycles more affordable than in Australia or the UK.

Risks are generally low but can include a small chance of egg damage during microinjection (about 5–10%), OHSS in around 1–5% of stimulation cycles, and a reduced but still possible risk of twins or multiples—now largely controlled with single embryo transfer. In some male infertility cases, there may be an underlying genetic cause that could be passed on to a male child. A few studies have also looked at rare epigenetic outcomes, but results are not consistent. Because of this, genetic counselling is usually part of care in NABH/JCI-accredited centres before ICSI, especially in male factor infertility cases.

ICSI is typically used when sperm-related issues are more serious, such as very low sperm count, poor motility, or abnormal shape. It’s also recommended when sperm isn’t present in the semen and needs to be retrieved surgically. Doctors may suggest it after previous IVF cycles with poor or no fertilisation, or when using frozen sperm that may have reduced quality after thawing. It is also commonly used alongside embryo genetic testing (like PGT-A) to improve fertilisation success and reduce the risk of cycle failure.

No. ICSI does not enable gender selection. The sex of the embryo depends on whether an X-bearing or Y-bearing sperm fertilises the egg — exactly as in natural conception. Gender selection through ICSI alone is not possible. Sex can only be found by checking embryos through PGT-A genetic testing after fertilisation and blastocyst culture. In India, using PGT-A for non-medical sex selection is banned under the PCPNDT Act and is not offered at Divinheal partner hospitals.

The first baby conceived through ICSI was born on 14 January 1992 at the Vrije Universiteit Brussel (VUB) in Belgium. Professor Gianpiero Palermo made the breakthrough, working under Professor André Van Steirteghem’s team. That child would be 33 years old in 2025. The first ICSI birth was published in The Lancet in 1992. Since then, millions of children have been born through ICSI globally.

Mukesh Ambani and Nita Ambani have not publicly confirmed using IVF or ICSI. Their children were born in the 1990s. At that time, IVF was not widely talked about in Indian public life. IVF and ICSI are private medical decisions. No public figure has to share them. IVF and ICSI use has grown a lot in India over the past three decades. ICMR data shows over 50,000 IVF cycles a year at registered clinics. Less stigma has led to more open talk about assisted reproduction.

Not always. Success rates depend on several patient-specific factors — the female partner’s age, embryo quality, ovarian reserve, and uterine health. Many patients do not get pregnant on the first cycle. Total live birth rates over 2–3 cycles are much higher than after just one try. Divinheal partner hospitals discuss realistic cycle-specific and total prognosis at the pre-cycle consultation.